![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > United Kingdom (GB)
Please find below persons from the United Kingdom (GB) or related to British organisations.Total search results: 2826 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Duncan, Alan (Prelude Ventures 200508) | Investment Manager | Prelude Ventures (Group) | United Kingdom (state/region unspecified) |
| Duncan, Alexander R. (Alex) (Agenus 201501– CTO before Actigen + Affitech + AstraZeneca + CAT) | Chief Technology/Technical Officer (CTO) | Agenus (Group) | Massachusetts (federal state) |
| Duncan, Kimbell (ConserV Bioscience 202101 CEO) | Chief Executive Officer (CEO) | ConserV Bioscience Ltd. | Greater London (region) |
| Duncan, Tommy (Touchlight 202103 CBO) | Chief Business Officer (CBO) | Touchlight (Group) | Greater London (region) |
| Dunlop, Sinclair (Epidarex Capital 201606 Managing Partner + Rock Spring Ventures 201301 Fund Manager EU) | Investment Manager | Epidarex Capital (Group) | Scotland |
| Dunn, Warwick (Univ Birmingham 201303) | Researcher (university / research institute) | University of Birmingham | West Midlands (region) |
| Dunnage, Samantha (Microsaic 201108– Head Marketing + Direct Sales before Uniqsis Ltd) | Sales Manager / Marketing Manager | Microsaic Systems plc (AIM: MSYS) | South East England (region) |
| Dunoyer, Marc (AstraZeneca 201311– CFO joined 201303 as EVP Global Portfolio + Product Strategy before GSK) | Chief Financial Officer (CFO) | AstraZeneca (Group) | East of England (region) |
| Dunphy, Anna (Walbrook PR 202109) | Public Relations Manager / Investor Relations Manager | Walbrook PR Ltd. | Greater London (region) |
| Durán, Cristina Ortega (AstraZeneca 202311 President of Evinova before CFO at AstraZeneca GmbH) | President/Director/Head Business Group/Unit/Division | AstraZeneca (Group) | Greater London (region) |
| Durkie, Andrew (Javelin Ventures 202212 Partner at Eos Advisory LLP) | Partner (venture partner) | Javelin Ventures (Group) | Scotland |
| Durrant, Lindy (Scancell 201712 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Scancell (Group) | South East England (region) |
| Dutton, Edward (Ed) (Northern Exposure PR 201507 Vice President) | Public Relations Manager / Investor Relations Manager | Northern Exposure Public Relations Ltd. (NEPR) | North West England (region) |
| D’Andrea, Larry (Spartan Bioscience 200909– CEO before Grant Thornton LLP Canada) | Chief Executive Officer (CEO) | Spartan Bioscience Inc. | Ontario |
| Earl, Michael (Celtic Pharma 201301 + Pro Bono Bio 201209 COO) | Partner (venture partner) | Auven Therapeutics (Group) | |
| Eastwick-Field, Vanessa (Carbosynth 201905 Managing Director) | Managing Director | Biosynth (since 9/22) (Group) | South East England (region) |
| Eaton, Andrew N. (Gentronix 201208– Commercial Serivces Manager before Shimadzu MALDI Marketing Manager Kratos) | Sales Manager / Marketing Manager | Gentronix Ltd. | North West England (region) |
| Ebeling, Thomas (UBS 201711 Standing Member of UBS Oncology Impact Fund former Novartis Pharma CEO) | Board member (all kinds of boards: supervisory, advisory, management etc.) | UBS (Group) | United Kingdom (state/region unspecified) |
| Eberhardt, Kai (Oviva 202109 CEO + Co-Founder) | n. a. | Oviva Ltd. | Greater London (region) |
| Ebsworth, David (Galenica 200910–201508 CEO Vifor Pharma RETIRES 8/14 before OGS CEO + Bayer Head Pharma | Board member, non-executive | Verona Pharma (Group) | Greater London (region) |
| Edelman, Michael (Nanoco Technologies 200801 CEO) | Chief Executive Officer (CEO) | Nanoco Technologies (Group) | North West England (region) |
| Edgson, Ray (Cambridge Consultants 201607 Ventures Director) | Investment Manager | Cambridge Consultants Ltd. | East of England (region) |
| Edwardes-Jones, Lucy (BGF (GB) 202011 Investor) | Investment Manager | BGF (GB) (Group) | Greater London (region) |
| Edwards, Glyn O. (Summit 201204– CEO before Antisoma CEO) | Chief Executive Officer (CEO) | Summit (Group) | South East England (region) |
| Edwards, Jon (Medicxi 201907 Partner) | Partner (venture partner) | Medicxi Ventures (formerly Index Ventures Life Sciences) | Greater London (region) |
| Edwards, Matthew (Schauenburg 201706 Separation Science Product Manager at SepSolve Analytical Ltd) | Product Manager (personnel) | Schauenburg (Group) | United Kingdom (state/region unspecified) |
| Edwards, Steve (VLA 200610 Chief Executive) | n. a. | United Kingdom (GB) (govt) | United Kingdom (state/region unspecified) |
| Edwardsson, Simon (V7 202211 Co-Founder) | Company Founder | V7 Ltd. (V7 Labs) | Greater London (region) |
| Efthymiopoulos, Konstantinos (Funxional Therapeutics 201005 CEO) | Chief Executive Officer (CEO) | Funxional Therapeutics Ltd. (FXT) | East of England (region) |
| Egerton, Mark (Quotient Bioresearch 201010) | n. a. | Quotient Bioresearch (Group) | East of England (region) |
| Egorov, Georgy (Vaccitech 202011– CFO before Exscientia + CompareEuropeGroup + UBS + Goldman Sachs) | Chief Financial Officer (CFO) | Vaccitech (Group) | South East England (region) |
| Ehrenheim, Peter (GE Healthcare 200608 LS CEO) | Chief Executive Officer (CEO) | General Electric (Group) | South East England (region) |
| Ek, Staffan (Axis-Shield 200603 Non-executive Director) | Board member, non-executive | Abbott (Group) | Scotland |
| Ekblom, Anders (AstraZeneca 199301– Executive VP Development before Karolinska Institutet) | Research & Development Manager | AstraZeneca (Group) | East of England (region) |
| Ellam, David (Juvenescence 201904– CFO before Silence Therapeutics + BioMarin + Plethora Solutions + Ark Therapeutics) | Chief Financial Officer (CFO) | Juvenescence (Group) | Virgin Islands (British Virgin Islands) |
| Ellingworth, Peter (ABHI 201101 CEO) | Chief Executive Officer (CEO) | ABHI (Association of British Healthcare Industries) | Greater London (region) |
| Elliott, Chris (Queen’s Univ Belfast 201607 Professor of Food Safety + Founder of IGFS) | Professor | University of Belfast (Queen’s University Belfast, QUB) | Northern Ireland |
| Elliott, Mary-Jane (Consilium SC 201307– Managing Partner + Co-founder before M:Communications) | Public Relations Manager / Investor Relations Manager | ICR (Group) | Greater London (region) |
| Ellis, David (Holtzbrinck 202306 Press, PR + Social Manager at Digital Science) | Public Relations Manager / Investor Relations Manager | Holtzbrinck (Group) | Greater London (region) |
| Ellis, Geoff (Proteome Sciences 201605 Finance Director) | Chief Financial Officer (CFO) | Proteome Sciences (Group) | South East England (region) |
| Emhiser, William (Bill) (Maine Manufacturing 2008– President before Whatman 200511–200701 CEO + Proteome Systems) | President/Director/Head Business Group/Unit/Division | General Electric (Group) | United Kingdom (state/region unspecified) |
| Emmerson, Greg (Stratophase 201110 CTO + co-founder) | Chief Technology/Technical Officer (CTO) | Stratophase Ltd. | South East England (region) |
| Emms, Jonathan (Circassia 201909– COO before Pfizer UK + GSK) | Chief Operating Officer (COO) | Circassia (Group) | South East England (region) |
| Enck, Robert J. (Bob) (ProtonDx 202206 President + Chair formerly CEO of Equinox Funds) | Board member, non-executive | ProtonDx Ltd. | Greater London (region) |
| Enegren, Nina (Huntsworth 201101 Citigate Dewe Rogerson London) | Public Relations Manager / Investor Relations Manager | Inizio (Group) | Greater London (region) |
| England, Claire (Covalent Bonds 2018– before Scott Partnership at Kapler Comms + Phoenix MarCom) | Public Relations Manager / Investor Relations Manager | Covalent Bonds LLC | Massachusetts (federal state) |
| Englerth, Chris (Phlexglobal 202001 Head Global Marketing) | Sales Manager / Marketing Manager | Phlexglobal (Group) | South East England (region) |
| English, Victoria (Evernow Publishing 201611 Editor at MedNous) | n. a. | Evernow Publishing Ltd. (MedNous) | Greater London (region) |
| Enright, Bill (Vaccitech 201908– CEO before Altimmune + GenVec + Biotech Venture Management + Life Technologies) | Chief Executive Officer (CEO) | Vaccitech (Group) | South East England (region) |
| Erler, Janine (Univ London 201102 Team Leader at Institute fo Cancer Research) | Researcher (university / research institute) | University of London | Greater London (region) |
| Escher, Dominik (Belleveue 201001 Managing Partner at BB Pureos Bioventures before ESBATech CEO + Founder) | Managing Partner | Bellevue (Group) | Channel Islands (Non-Commonwealth / Non-EU tax haven) |
| Esinhart, Jim (Chiltern 201707 CEO) | Chief Executive Officer (CEO) | Chiltern (Group) | South East England (region) |
| Espinet, Antoine Jean (MicrofluidX 201810– CEO + Founder) | Chief Executive Officer (CEO) | MicrofluidX Ltd. | East of England (region) |
| Evans, Christopher (Chris) (Arthurian Life Sciences + Merlin Biosciences + Chiroscience + Celsis + Enzymatix) | Investment Manager | Arix Bioscience (Group) | Wales |
| Evans, David (201204 Board Chairman of EKF Diagnostics + Omega Diagnostics + Episteim former Axis-Shield Director) | Board member, non-executive | EKF Diagnostics (Group) | Wales |
| Evans, Hilary (Alzheimer’s Research UK 202212 Chief Executive) | Chief Executive Officer (CEO) | Alzheimer’s Reserach UK | East of England (region) |
| Evans, John (Simcyp 201202 Managing Director) | Managing Director | Vector Capital | Yorkshire and the Humber (region) |
| Evans, Liam (Hypha Discovery 201003 CEO) | Chief Executive Officer (CEO) | Hypha Discovery Ltd. | Greater London (region) |
| Evans, Michael (Mike) (OGT 200503– CEO before Amersham/GE) | Chief Executive Officer (CEO) | Sysmex (Group) | South East England (region) |
| Evans, Richard (EKF Diagnostics 201307– COO before Finance Director) | Chief Operating Officer (COO) | EKF Diagnostics (Group) | Wales |
| Evans, Sarah (Scott Partnership 201203) | Public Relations Manager / Investor Relations Manager | Scott Partnership (Scott PR) (Group) | North West England (region) |
| Evans, Thomas G. (Tom) (Vaccitech 201908– CSO before CEO before Vical + Novartis + Aeras) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Vaccitech (Group) | South East England (region) |
| Evenden, Anja (Vego Ltd 201401 Marketing Executive) | Sales Manager / Marketing Manager | Vego Ltd. | Greater London (region) |
| Evershed, Richard P. (Univ Bristol 200910 Prof + Head NERC LSMSF) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | University of Bristol | South West England (region) |
| Evetts, Ian (Glythera 201801 CBO) | Chief Business Officer (CBO) | Iksuda Therapeutics Ltd. | North East England (region) |
| Ezendam, Anne Marieke (Optimum Strategic Communications 201904) | Public Relations Manager / Investor Relations Manager | Optimum Strategic Communications | Greater London (region) |
| Fagerlund, Susanne (Cellectricon 201206 VP Market Communications) | public relations / investor relations | Cellectricon (Group) | Västra Götaland |
| Faichney, Alan (Arrayjet 201308– Board Chairman before Edinburgh Instruments CEO et al) | Board member, non-executive | Arrayjet Ltd. | Scotland |
| Fairhead, Heather (Phico Therapeutics 201808 CEO) | Chief Executive Officer (CEO) | Phico Therapeutics Ltd. | East of England (region) |
| Fairhead, Rona (United Kingdom (govt) 201801 Minister of State for Trade and Exports) | Minister | United Kingdom (GB) (govt) | Greater London (region) |
| Fallon, Rachel (Sense Proteomic 200806 CEO before Procognia VP RnD) | Chief Executive Officer (CEO) | Sysmex (Group) | United Kingdom (state/region unspecified) |
| Fallowfield, Barbara (BIVDA 201611 Managing Director) | Managing Director | BIVDA (British In Vitro Diagnostic Regulatory Association) | Greater London (region) |
| Famm, Kris (GSK 201608– President Galvani Bioelectronics before VP Bioelectronics RnD + Head Protein Degration Tech) | President/Director/Head Business Group/Unit/Division | GSK (Group) | East of England (region) |
| Fang, Guowei (GenScript 202311 CSO + Head of Business Development at Legend Biotech) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | GenScript (Group) | Cayman Islands (British Overseas Territory) |
| Farooq, Khurem (Aiolos Bio 202301– CEO + Co-Founder before Gyroscope Therapeutics + Genentech) | Chief Executive Officer (CEO) | GSK (Group) | California (federal state) |
| Farquharson, Andrew (MRC Technology 201507– Technology Transfer Director before AstraZeneca et al) | IP Manager | LifeArc (GB) | Greater London (region) |
| Farrant, Elizabeth (Cyclofluidic 2011– CBO before Pfizer UK Sandwich) | Chief Business Officer (CBO) | Pfizer (Group) | East of England (region) |
| Farrar, Jeremy (Wellcome Trust 201403 Director) | n. a. | Wellcome Trust, The | Greater London (region) |
| Farrell, Lindsay (BioPharmaSpec 201802 Head of Business Development) | Business Development Manager / Strategy Manager | BioPharmaSpec (Group) | Channel Islands (Non-Commonwealth / Non-EU tax haven) |
| Faure, Alexia (NewCap 201705– Consultant before Hume Brophy since 201409) | Public Relations Manager / Investor Relations Manager | NewCap. – Investor Relations & Financial Communications | Île-de-France (region) |
| Fear, Harriet (Deyton Bell 201901– Director before Consultant + One Nucleus 2009–201707 CEO + British Foreign Service) | President/Director/Head Business Group/Unit/Division | Deyton Bell Ltd. | East of England (region) |
| Fearnley, Joel (Lab901 200805 CEO + Co-Founder) | Chief Executive Officer (CEO) | Agilent (Group) | Scotland |
| Featherstone, Lucy (Consilium Strategic Communications 202104) | Public Relations Manager / Investor Relations Manager | ICR (Group) | Greater London (region) |
| Feeter, Kale (Ori Biotech 202208– Director of Business Development before Cytiva + Thermo Fisher) | Business Development Manager / Strategy Manager | Ori Biotech (Oribiotech) (Group) | Greater London (region) |
| Feilding Mellen, Cosmo (Beckley Psytech 202108 CEO) | Chief Executive Officer (CEO) | Beckley Psytech Ltd. | South East England (region) |
| Feilding, Amanda C. M. (Beckley Foundation 1998– Founder) | n. a. | Beckley Foundation | South East England (region) |
| Feldmann, Jörg (Univ Aberdeen 201309 Professor) | Professor | University of Aberdeen, Element Speciation Laboratory | Scotland |
| Fell, Tim (Synthace 201812 CEO) | Chief Executive Officer (CEO) | Synthace (Group) | Greater London (region) |
| Fellner, Peter (Acambis 200703 President) | Board member, non-executive | Sanofi (Group) [since May 2011] | East of England (region) |
| Fellows, David (Beacon Therapeutics 202306 CEO formerly NightstaRx 201511 CEO) | Chief Executive Officer (CEO) | Beacon Therapeutics (Group) | Greater London (region) |
| Fennell, Amber (Bielecka, Amber) (Consilium Strategic Communications 201307– Co-founder) | Company Founder | ICR (Group) | Greater London (region) |
| Fenzl, Edgar J. (FGK Clinical Research 201411 Managing Director + Co-founder) | Managing Director | FGK Clinical Research GmbH | Bayern (federal state) |
| Ferguson, Elaine (Biopta 201511 Finance Director) | Chief Financial Officer (CFO) | ReproCell (Group) | Scotland |
| Ferguson, Elaine (Huntsworth 202106 CEO of Medistrava) | Chief Executive Officer (CEO) | Inizio (Group) | Greater London (region) |
| Ferguson, Mark (Renovo 200010– CEO) | Chief Executive Officer (CEO) | Renovo Group plc | North West England (region) |
| Fernandes, Daryl (Ludger 1999– founder + 8/05 existent CEO) | Chief Executive Officer (CEO) | Ludger Ltd. | South East England (region) |
| Fernandez, Anthony (Refeyn 202101–202301 CEO before Teledyne + Xennia Technology LEFT 1/23 for health reasons) | Chief Executive Officer (CEO) | Refeyn (Group) | South East England (region) |
| Fewster, Martin (World Trade Group 201203 Marketing Manager at WTG Events) | Sales Manager / Marketing Manager | World Trade Group Ltd. (WTG) | Greater London (region) |
| Field, James (LabGenius 201711 CEO + Founder) | Chief Executive Officer (CEO) | LabGenius (GB) | Greater London (region) |
| Fiennes, Martin (Oxford Science Enterprises 202205 Principal) | Principal (venture capital) | Oxford Science Enterprises (Group) | South East England (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
